Servicio de Aparato Digestivo, Hospital Universitario de Bellvitge, Hospitalet de Llobregat, Barcelona, España.
Servicio de Enfermedades Infecciosas, Hospital Clínic, Barcelona, España.
Gastroenterol Hepatol. 2021 Feb;44(2):175-180. doi: 10.1016/j.gastrohep.2020.07.027. Epub 2020 Oct 23.
Faecal microbiota transplantation (FMT) is an effective and safe treatment of recurrent Clostridioides difficile infection. It is essential to make every effort to perform FMT rigorously and based on scientific knowledge. Selection of the faecal microbiota donor is a key part of the process to ensure recipient safety. Protocols of action must be implemented that allow clinicians to act with the maximum guarantees and to minimise the risks of the procedure. In this regard, a multidisciplinary working group has been set up with the aim of establishing recommendations for selecting the faecal microbiota donor.
粪便微生物群移植(FMT)是治疗复发性艰难梭菌感染的有效且安全的方法。必须尽一切努力严格地基于科学知识进行 FMT。选择粪便微生物群供体是确保受者安全的过程中的关键部分。必须实施行动方案,使临床医生能够最大限度地保证并将程序的风险降至最低。在这方面,成立了一个多学科工作组,旨在为选择粪便微生物群供体制定建议。